Apogee’s Long-Acting Eczema Shot Keeps Skin Clear with Just 2 Injections a Year

Apogee Therapeutics’ Phase 2 data show zumilokibart maintains strong skin clearance and itch relief in moderate-to-severe eczema for 52 weeks with dosing every 3 or 6 months.